Ynetnews reports: Israeli scientists from the Rehovot-based company Nucleix succeeded in developing a first of its kind blood test to diagnose lung cancer.
The new test is able to diagnose the disease long before it spreads in the body, thus increasing the chance of survival, as many patients usually die within a few months of the diagnosis.
Each year, approximately 1.8 million new lung cancer patients are diagnosed, a 1.59 million of whom will die within the first year post-diagnosis. Most cases are discovered by chance, after a screening test, or due to abnormal symptoms such as prolonged cough, bloody cough, breathing difficulties or weight loss.
Read more here.
COMMENTS
Please let us know if you're having issues with commenting.